FLGT
Fulgent Genetics·NASDAQ
--
--(--)
--
--(--)
4.50 / 10
Netural
With a fund flow rating of 7.8/10, the stock shows robust fund flow characteristics. Supportive momentum from overall, block, Small, Medium, and Large trends is partially offset by concerning Extra-large patterns, pointing to positive capital flow trajectory. Analyst coverage indicates divided analyst consensus with neutral perspective. Rating distribution: Neutral(100.0%) among 1 analysts, supported by 1.21 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-11
InstitutionPiper Sandler
Times predicted4
Historical Win Rate25.0%
Is money flowing into or out of FLGT?
- FLGT holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.50/10 (Netural).
